title: A comparative genomic approach for identifying synthetic lethal interactions in human cancer.
abstract: Synthetic lethal interactions enable a novel approach for discovering specific genetic vulnerabilities in cancer cells that can be exploited for the development of therapeutics. Despite successes in model organisms such as yeast, discovering synthetic lethal interactions on a large scale in human cells remains a significant challenge. We describe a comparative genomic strategy for identifying cancer-relevant synthetic lethal interactions whereby candidate interactions are prioritized on the basis of genetic interaction data available in yeast, followed by targeted testing of candidate interactions in human cell lines. As a proof of principle, we describe two novel synthetic lethal interactions in human cells discovered by this approach, one between the tumor suppressor gene SMARCB1 and PSMA4, and another between alveolar soft-part sarcoma-associated ASPSCR1 and PSMC2. These results suggest therapeutic targets for cancers harboring mutations in SMARCB1 or ASPSCR1 and highlight the potential of a targeted, cross-species strategy for identifying synthetic lethal interactions relevant to human cancer.
authors: Authors' Affiliations: Department of Computer Science and Engineering; Program in Biomedical Informatics and Computational Biology, University of Minnesota, Minneapolis; Department of Surgery, Mayo Clinic, Rochester, Minnesota; Department of Laboratory Medicine & Pathology, Molecular Genetics Lab, Mayo Clinic, Rochester, Minnesota; Department of Molecular Genetics, Terrence Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Ontario, Canada; Chemical Genomics Research Group, RIKEN Advance Science Institute, Saitama, Japan; and Great Lakes Bioenergy Research Center, University of Wisconsin, Madison, Wisconsin.
authors: Raamesh
authors: R
authors: Deshpande
authors: Michael K
authors: MK
authors: Asiedu
authors: Mitchell
authors: M
authors: Klebig
authors: Shari
authors: S
authors: Sutor
authors: Elena
authors: E
authors: Kuzmin
authors: Justin
authors: J
authors: Nelson
authors: Jeff
authors: J
authors: Piotrowski
authors: Seung Ho
authors: SH
authors: Shin
authors: Minoru
authors: M
authors: Yoshida
authors: Michael
authors: M
authors: Costanzo
authors: Charles
authors: C
authors: Boone
authors: Dennis A
authors: DA
authors: Wigle
authors: Chad L
authors: CL
authors: Myers
mesh_terms: D000818:Animals; D018929:Cell Culture Techniques; D002868:Chromosomal Proteins, Non-Histone / Q000235:genetics; D004268:DNA-Binding Proteins / Q000235:genetics; D023281:Genomics; D006801:Humans; D009369:Neoplasms / Q000235:genetics* / Q000378:metabolism; D034741:RNA, Small Interfering / Q000235:genetics / Q000378:metabolism; D000071796:SMARCB1 Protein; D014157:Transcription Factors / Q000235:genetics
chemical_list: D002868:Chromosomal Proteins, Non-Histone; D004268:DNA-Binding Proteins; D034741:RNA, Small Interfering; D000071796:SMARCB1 Protein; C513266:SMARCB1 protein, human; D014157:Transcription Factors
references: Proc Natl Acad Sci U S A. 2011 Jul 26;108(30):12372-7
references: 21746896
references: Lancet. 2010 Jul 24;376(9737):235-44
references: 20609467
references: Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3461-6
references: 18305163
references: Cancer Discov. 2012 Feb;2(2):172-189
references: 22585861
references: Nature. 2005 Apr 14;434(7035):913-7
references: 15829966
references: Biometrika. 1947;34(1-2):28-35
references: 20287819
references: Oncogene. 1999 Dec 9;18(52):7559-65
references: 10602515
references: Nature. 2009 Nov 5;462(7269):108-12
references: 19847166
references: Cell. 2009 May 29;137(5):835-48
references: 19490893
references: Biometrics. 1946 Dec;2(6):110-4
references: 20287815
references: Mol Syst Biol. 2010 Nov 16;6:429
references: 21081923
references: Cancer Res. 2009 Nov 1;69(21):8223-30
references: 19843852
references: Cancer Res. 2009 Oct 1;69(19):7844-50
references: 19789337
references: Science. 1997 Nov 7;278(5340):1064-8
references: 9353181
references: Science. 2010 Jan 22;327(5964):425-31
references: 20093466
references: Cancer Res. 2005 May 15;65(10):4012-9
references: 15899790
references: J Clin Invest. 2012 Aug;122(8):2983-8
references: 22797305
references: Nat Rev Cancer. 2004 Mar;4(3):177-83
references: 14993899
references: Nucleic Acids Res. 2010 Jan;38(Database issue):D196-203
references: 19892828
references: CSH Protoc. 2006 Jun 01;2006(1):
references: 22485582
references: N Engl J Med. 2009 Jul 9;361(2):123-34
references: 19553641
references: Cancer Res. 2001 Apr 1;61(7):3071-6
references: 11306489
references: Oncogene. 2009 Apr 9;28(14):1653-68
references: 19234488
references: Cell. 2012 Aug 17;150(4):842-54
references: 22901813
references: Cell. 2009 May 29;137(5):821-34
references: 19490892
references: Methods Enzymol. 2010;470:145-79
references: 20946810
references: J Clin Pathol. 2006 Nov;59(11):1127-32
references: 17071801
references: Oncogene. 2001 Jan 4;20(1):48-57
references: 11244503
references: Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3276-81
references: 19218431
references: Am J Hum Genet. 2010 Feb 12;86(2):279-84
references: 20137775
references: Nat Rev Drug Discov. 2007 Jul;6(7):556-68
references: 17599085